Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 27;59(14):5660-5664.
doi: 10.1002/anie.201915870. Epub 2020 Feb 20.

Enantioselective Synthesis of 1,12-Disubstituted [4]Helicenes

Affiliations

Enantioselective Synthesis of 1,12-Disubstituted [4]Helicenes

Thierry Hartung et al. Angew Chem Int Ed Engl. .

Abstract

A highly enantioselective synthesis of 1,12-disubstituted [4]carbohelicenes is reported. The key step for the developed synthetic route is a Au-catalyzed intramolecular alkyne hydroarylation, which is achieved with good to excellent regio- and enantioselectivity by employing TADDOL-derived (TADDOL=α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanol) α-cationic phosphonites as ancillary ligands. Moreover, an appropriate design of the substrate makes the assembly of [4]helicenes of different substitution patterns possible, thus demonstrating the synthetic utility of the method. The absolute stereochemistry of the newly prepared structures was determined by X-ray crystallography and characterization of their photophysical properties is also reported.

Keywords: Au catalysis; [4]helicenes; asymmetric catalysis; enantioselective synthesis; ligand design.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Inversion barriers for [4]‐, [5]‐, and [6]helicenes and their Me‐substituted derivatives; [a] Calculated values at the B3LYP/6‐31G(d) level of theory; [b] Experimental values.
Figure 2
Figure 2
Synthetic approaches to the enantioselective synthesis of 1,12‐disubstituted [4]helicenes.
Scheme 1
Scheme 1
Synthesis of [4]helicene precursors and structures of the catalysts tested. Reagents and conditions: a) Pd2(dba)3 (5 mol %), SPhos (10 mol %), Cs2CO3 (4 equiv), THF/H2O (10:1), 80 °C, 24 h, 3 a, 62 %; 3 b, 67 %; 3 c, 65 %; 3 d, 89 %; b) 19 (9 mol %), AgSbF6 (9 mol %), DCM, 7 a, 87 %; 7 b, 42 %, both from 6 (two steps); c) Tf2O (1.5 equiv), pyridine (4.0 equiv), and then 5 a or 5 c, Pd2(dba)3 (5 mol %), SPhos (10 mol %), Cs2CO3 (2 equiv), THF/H2O (10:1), 80 °C, 24 h, 8 a, 60 %; 8 b, 25 % (two steps). X‐ray structure of 2 g, H atoms, co‐crystallized solvents and SbF6 anions are removed for clarity. Arene moieties are drawn as reduced sticks, ellipsoids drawn at 50 % probability level.16
Scheme 2
Scheme 2
Synthesis of non‐symmetric [4]helicene precursors. Reagents and conditions: a) Pd(AcO)2 (3 mol %), SPhos, (3 mol %), K3PO4 (2.0 equiv), toluene/dioxane (10:1), 12 a, 92 %, 12 b, 91 %, 12 c, 87 %; b) Ohira–Bestmann reagent (3.0 equiv), K2CO3 (3.0 equiv), MeOH, 13 a, 95 %, 13 b, 99 %, 13 c, 87 %; c) PhI (1.0 equiv), CuI (3 mol %), PdCl2(PPh3)2 (2 mol %), Et3N (5 mL), 14 c, 89 %, 14 d, 71 %; d) PtCl2 (10 mol %), toluene, 85 °C, 15 a, 60 %; 15 b, 89 %; e) 19 (10 mol %), AgSbF6 (10 mol %), DCM, 15 c, 73 %; 15 d, not isolated; f) BBr3, DCM, 16 a, 99 %; 16 b, 85 %; 16 c, 73 %; g) BCl3 (2 equiv), C6HMe5 (3 equiv),16 d, 67 % (two steps); h) Tf2O (1.2 equiv), Et3N, 17 a, 79 %; 17 b, 75 %; 17 c, 98 %, 17 d, 95 %; i) 5 ac, Pd2(dba)3 (5 mol %), SPhos (10 mol %), Cs2CO3 (2 equiv), THF/H2O (10:1), 80 °C, 24 h, 18 a, 89 %; 18 b, 92 %; 18 c, 68 %; 18 d, 51 %; 18 e, 43 %; 18 f, 38 %; 18 g, 67 %; 18 h, 75 %; 18 i, 62 %; 18 j, 81 %.
Figure 3
Figure 3
X‐ray structure of rac1 a (left) and 20 j (right). H atoms are removed for clarity and ellipsoids drawn at 50 % probability level.16
Figure 4
Figure 4
Circular dichroism spectra of 1 ae in dichloromethane.

References

    1. None
    1. Shen Y., Chen C.-F., Chem. Rev. 2012, 112, 1463–1535; - PubMed
    1. Gingras M., Chem. Soc. Rev. 2013, 42, 968–1006; - PubMed
    1. Gingras M., Félix G., Peresutti R., Chem. Soc. Rev. 2013, 42, 1007–1050; - PubMed
    1. Gingras M., Chem. Soc. Rev. 2013, 42, 1051–1095; - PubMed

LinkOut - more resources